Older Donation After Circulatory Death Kidneys for Older Recipients: A Single-Center Experience.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 01 10 2018
revised: 02 01 2019
accepted: 17 01 2019
entrez: 14 4 2019
pubmed: 14 4 2019
medline: 14 6 2019
Statut: ppublish

Résumé

The number of older patients is increasing on the transplant waiting list. Donation after circulatory death (DCD) kidney transplantation has increased, but there remains hesitancy in use of older DCD organs. The aim of this study was to evaluate outcomes of directing older DCD donor kidneys into older recipients. Patients 60 years or older who received transplants from DCD donors 60 years or older, between February 2010 and January 2014, were identified from a prospectively maintained database. Over a 4-year period, 88 patients 60 years or older received DCD kidney transplants from donors 60 years or older. Of these 44 (55%) were 60 to 69 years old and 40 (45%) were 70 years or older. Median follow up was 63 months. Patient survival was 95% and 79% at 1 and 5 years, respectively, with a survival in those 70 years and older (69%) compared with those aged 60 to 69 (88%) years (P = .01). Censored for death graft survival was 94% and 80% at 1 and 5 years, respectively. Median estimated glomerular filtration rate at 12 months and 36 months was 36 mL/min (range, 11-70 mL/min) and 39.5 mL/min (range, 11-77 mL/min), respectively. Older DCD kidneys, when transplanted into older recipients, result in good patient and graft survival and an acceptable graft function, especially considering their age. This represents a good use of this organ resource.

Identifiants

pubmed: 30979453
pii: S0041-1345(18)31292-2
doi: 10.1016/j.transproceed.2019.01.081
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

701-706

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

U Khalid (U)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom. Electronic address: usman.khalid@doctors.org.uk.

M Jameel (M)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

T Sabah (T)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

L Szabo (L)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

M A Ilham (MA)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

R Chavez (R)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

E Ablorsu (E)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

A Asderakis (A)

Cardiff Transplant Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH